Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
...th the third quarter of fiscal 2008. Year-to-date orthopat
disposables revenue is $26 million, up 5%.
...ic $22,967 $18,981 21.0%
$9,112 $9,086 ...ic $66,077 $50,907 29.8%
$26,301 $25,122 ...
Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
...nue was $9 million for the quarter, up 10%.
disposables revenue was $34 million, up 12%. The Company
placed more than 175 orthopat
devices in the field in fiscal 2008.
Equipment pla...178 $17,254 22.7% 72,085 66,552 8.3% orthopat
$9,179 $8,383 9.5% 34,301 ...
Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
through Haemonetics' Surround software.
disposables revenue was $9 million for the quarter, up 21.3%.
disposables revenue is $25 million, up 13.5%. The
Company has placed more than 130 orthopat
devices in the field this fiscal
year. Equipment p...
Haemonetics' Webcast Presentation
...drivers. These are plasma consumables, which are
expected to grow 10-13% annually; red cell consumables which are expected
to grow about 10% annually; orthopat
consumables, which are expected to
grow 10-15% annually, and software and services which is expected to grow
18-22% annually. Haemonetics (NYSE: HAE...
Description:... Like other blood salvage devices, the Haemonetics orthopat
system collects and cleanses red blood cells lost during and after surgery,...lood cells.
For orthopedic patients, surgical blood salvage with the orthopat
system means a reduced need for donor blood and a lowered risk of receiving...